U.S. Retail Distributors Stock News

ORIC Pharmaceuticals (ORIC) came under pressure after Ipsen pulled cancer drug Tazverik over concerns about secondary hematologic malignancies, even though ORIC said its prostate cancer candidate rinzimetostat showed no malignancies in preclinical toxicity testing. See our latest analysis for ORIC Pharmaceuticals. At a share price of US$11.90, ORIC has seen a 19.12% 30 day share price return and 45.65% year to date. The 1 year total shareholder return of 52.76% and 3 year total shareholder...

Boeing (BA) is back in the spotlight after disclosing minor electrical wiring damage on undelivered 737 MAX jets, a quality issue that has weighed on the share price despite steady full year delivery guidance. See our latest analysis for Boeing. Those wiring disclosures have fed into recent share price weakness, with Boeing’s 7 day share price return of 9.18% and 30 day return of 13.61% standing in contrast to a 1 year total shareholder return of 29.71%. This suggests momentum has cooled in...

Simmons First National (NasdaqGS:SFNC) reported quarterly results that exceeded revenue and EPS expectations. The bank highlighted resilient operations and solid performance within its regional banking footprint. The update adds fresh information on the company’s current business momentum that has not been reflected in recent coverage. Simmons First National, trading at $18.61, has delivered a quarter that came in ahead of both revenue and earnings forecasts, which puts a fresh spotlight on...

Recent share performance context Ross Stores (ROST) has drawn investor attention after its shares delivered a 68.3% total return over the past year, along with a 12.9% gain year to date and a 12% return in the past 3 months. See our latest analysis for Ross Stores. At a share price of US$206.28, Ross Stores has recently eased back over the past week even after a solid 30 day share price return, while its 1 year total shareholder return of 68.3% and 3 year total shareholder return of 108.6%...

The Mosaic Company recently announced a quarterly dividend of US$0.2200 per share payable on June 2, 2026, while also advancing plans with Rainbow Rare Earths Ltd. to develop the Uberaba rare earths project in Brazil through new processing facilities targeting production by 2030. This move signals Mosaic’s effort to extract more value from its existing phosphate operations by recovering rare earth elements, potentially diversifying revenue beyond traditional fertilizers. Next, we’ll examine...

This article examines whether Petco Health and Wellness Company, at around US$3.62, may represent a bargain or a value trap by exploring what the current share price might indicate about the business. The stock has recently experienced sharp moves, with returns of 52.1% over the last 7 days, 44.2% over the last 30 days, 27.0% year to date and 51.5% over the last year. However, the 3 year and 5 year returns show declines of 63.1% and 84.4%, which tells a very different story. These swings...

In late 2025, Corcept Therapeutics received a Complete Response Letter from the FDA rejecting its New Drug Application for relacorilant on the grounds of insufficient evidence of effectiveness, prompting multiple securities class action lawsuits alleging the company misrepresented the drug’s regulatory prospects and prior FDA feedback. These lawsuits focus not just on the setback for relacorilant, but on claims that Corcept withheld repeated FDA concerns while continuing to promote the drug...

Old Republic International (NYSE:ORI) has appointed Doug Wordekemper as CEO of Old Republic Professional. The move is part of a broader organizational leadership change within the Professional division. The appointment brings a leader with extensive industry experience into a key role overseeing the Professional business. Old Republic International, through its Professional division, focuses on specialty insurance solutions for professional liability and related risks. Leadership changes in...

Subscriber milestone puts Karooooo (KARO) in focus Cartrack, a subsidiary of Karooooo (KARO), has surpassed two million active subscribers in South Africa. This milestone puts the group’s mobility SaaS model and customer-focused execution firmly on investors’ radar. See our latest analysis for Karooooo. Karooooo’s latest subscriber milestone lands after a period where the share price has moved steadily rather than sharply, with a 5.69% year to date share price return and a 19.93% one year...

If you are wondering whether WEX at around US$159.95 is priced fairly or offering value, you are not alone. This article is built to help you assess that question using several valuation tools. The stock has been relatively mixed recently, with a 7.8% return year to date and 3.8% over the last year, alongside a 4.3% decline over the past week and a 1.4% gain over the last 30 days. These movements can change how the market is thinking about its risk and opportunity. Recent coverage has...

The National Transportation Safety Board plans to hold a hearing on Ford Motor's BlueCruise hands free driving system following two fatal crashes. The hearing will examine how the advanced driver assistance system was used in the incidents and whether additional safety measures are needed. The review puts Ford's automated driving technology and safety practices under closer regulatory and public scrutiny. For investors watching NYSE:F at a current share price of $11.67, this hearing comes...

LKQ stock performance context LKQ (LKQ) shares closed at $29.34, with the stock showing a 1 day return of 1.38% and a 7 day decline of 6.77%. This sets the stage for a closer look at its recent performance. See our latest analysis for LKQ. At the current share price of $29.34, LKQ’s 30 day share price return of a 13.96% decline sits alongside a 1 year total shareholder return of a 26.95% decline, pointing to fading momentum rather than a short term blip. If LKQ’s recent pullback has you...

Earlier this month, AT&T announced over US$250.00 billion of planned U.S. connectivity investment through 2030, launched more flexible Unlimited Your Way wireless plans, and issued long-dated Canadian dollar bonds to support its network build-out. Together, these moves highlight AT&T’s push to reposition itself as a core connectivity platform for AI-era data demand while sharpening its consumer value proposition. Now we’ll examine how AT&T’s US$250.00 billion connectivity build-out plan...

Why Celldex Therapeutics (CLDX) is on investors’ radar today Celldex Therapeutics (CLDX) has drawn attention after recent trading, with shares last closing at $29.51 and showing mixed returns over the past week, month, past 3 months, and year. See our latest analysis for Celldex Therapeutics. Recent trading has been choppy, with a 30 day share price return of 28.30% and a 1 year total shareholder return of 44.52%, set against a weaker 3 year total shareholder return of 29.47% and a 5 year...

Recent share performance and business snapshot Titan America (TTAM) has drawn attention after a one month return showing a 16.1% decline, extending a past 3 months slide of 7.8%. This has prompted investors to reassess the cement and building materials producer. The Brussels based company reports annual revenue of US$1.65b and net income of US$178.46m, with recent revenue growth of 6.3% and net income growth of 13.7%. This has put a spotlight on how earnings support the current share...

G-III Apparel Group has reported a weaker fourth quarter for fiscal 2026, with sales falling to US$771.49 million and a net loss of US$31.94 million, while also guiding to lower near-term revenue and earnings as it exits Calvin Klein and Tommy Hilfiger licenses and absorbs charges related to the Saks Global bankruptcy. Alongside these softer results, the company reaffirmed its portfolio shift toward higher-margin owned brands, announced a US$0.10 quarterly dividend, and outlined a US$25...

PENN Entertainment (PENN) is back on investors’ radar after announcing a 203-room hotel tower and an expanded high-limit table games room at Hollywood Casino Columbus, both pending regulatory approvals. See our latest analysis for PENN Entertainment. Despite the hotel and high limit room expansion plans and the recent earnings surprise in Q4 2025, sentiment around PENN has been mixed. A 21.68% 1 month share price return contrasts with a 16.27% 1 year total shareholder return decline and an...

IDEAYA Biosciences (IDYA) enrolled the first patient in its Phase 1 IDE892 trial for MTAP-deleted solid tumors and updated investors on its broader MTAP-deletion and CDKN2A-deficiency pipeline. The company also trimmed certain combination studies. See our latest analysis for IDEAYA Biosciences. The latest IDE892 trial update comes after a 1-month share price return of 9.32% and a 1-year total shareholder return of 78.09%, suggesting recent momentum on top of already strong longer term...

Earlier this month, Jones Lang LaSalle unveiled its Accelerate 2030 plan, pairing new long-term financial targets with an enlarged share repurchase authorization of US$4.40 billion, including a US$200 million accelerated buyback. This combination of technology-led growth ambitions and a very large capital return commitment marks a meaningful shift in how JLL is positioning itself for clients and shareholders through 2030. Next, we’ll consider how JLL’s significantly expanded share buyback...

Setting the scene on U.S. Physical Therapy With no fresh headline event driving U.S. Physical Therapy (USPH) today, investors are left weighing a share price of $76.83 alongside recent return figures and the company’s latest reported revenue and net income. See our latest analysis for U.S. Physical Therapy. The recent share price pullback, including a 1-day share price return of 1.35% decline and a 30-day share price return of 11.63% decline, sits alongside a 1-year total shareholder return...

In early March 2026, AAON reported fourth-quarter 2025 results showing US$424.22 million in sales and full-year earnings per share of US$1.29, while also affirming a regular quarterly dividend of US$0.10 per share payable on March 30, 2026. At the same time, AAON highlighted its Alpha Class EXTREME SERIES rooftop unit’s success in the U.S. Department of Energy’s HVAC Technology Challenge, underlining how advanced dual-fuel heat pump capability and cold-weather performance could reinforce...

Wix.com Ltd. recently reported its fourth-quarter 2025 results, showing revenue of US$524.27 million and a net loss of US$40.23 million, alongside full-year 2025 revenue of US$1.99 billion and net income of US$50.65 million. On the same day, Wix.com issued mid-teens percentage revenue growth guidance for both the first quarter and full year 2026 and secured a US$250,000,000 private placement featuring warrants and lock-up agreements with Durable Capital Partners and other investors,...

In recent months, Driehaus Capital Management and Deerfield Management Company have sharply increased their holdings in Praxis Precision Medicines, adding hundreds of thousands of shares and committing a combined investment of more than US$346.79 million as the company filed two FDA new drug applications for ulixacaltamide and relutrigine. This combination of larger institutional ownership, advancing late‑stage neuroscience candidates and a cash position supported by roughly US$1.55 billion...

Earlier in March, Federated Hermes announced that four of its investment strategies received LSEG Lipper Fund Awards 2026 US for consistently strong risk‑adjusted performance, while CEO J. Christopher Donahue is scheduled to present at the RBC Capital Markets Global Financial Institutions Conference 2026 in New York on March 11. This combination of third‑party recognition and high recent earnings growth and return on equity is sharpening attention on how effectively Federated Hermes converts...